Percentages of intermediate hematopoietic progenitors that express HIV-1 entry receptors
| . | . | CD4 . | . | X4 . | . | 4X4DP . | . | R5 . | . | 4R5DP . | . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Population . | Source . | Range . | P* . | Range . | P* . | Range . | P* . | Range . | P* . | Range . | P* . |
| CMP | CB | 5 ± 3 | .77 | 36 ± 11 | .50 | 2 ± 2 | .62 | 9 ± 5 | .50 | 2 ± 1 | .28 |
| FL | 7 ± 3 | 24 ± 12 | 2 ± 1 | 5 ± 3 | 1 ± .1 | ||||||
| GMP | CB | 8 ± 5 | .64 | 35 ± 11 | .22 | 2 ± .1 | .40 | 7 ± 4 | .56 | 2 ± .1 | .89 |
| FL | 5 ± 3 | 53 ± 6 | 4 ± 3 | 10 ± 3 | 2 ± 1 | ||||||
| MEP | CB | 2 ± 2 | .59 | 29 ± 7 | .3 | 0.4 ± 0.1 | .37 | 1 ± 1 | .53 | 0.1 ± 0.1 | .57 |
| FL | 1 ± .3 | 19 ± 4 | 0.2 ± .07 | 2 ± 1 | 0.1 ± 0.03 |
| . | . | CD4 . | . | X4 . | . | 4X4DP . | . | R5 . | . | 4R5DP . | . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Population . | Source . | Range . | P* . | Range . | P* . | Range . | P* . | Range . | P* . | Range . | P* . |
| CMP | CB | 5 ± 3 | .77 | 36 ± 11 | .50 | 2 ± 2 | .62 | 9 ± 5 | .50 | 2 ± 1 | .28 |
| FL | 7 ± 3 | 24 ± 12 | 2 ± 1 | 5 ± 3 | 1 ± .1 | ||||||
| GMP | CB | 8 ± 5 | .64 | 35 ± 11 | .22 | 2 ± .1 | .40 | 7 ± 4 | .56 | 2 ± .1 | .89 |
| FL | 5 ± 3 | 53 ± 6 | 4 ± 3 | 10 ± 3 | 2 ± 1 | ||||||
| MEP | CB | 2 ± 2 | .59 | 29 ± 7 | .3 | 0.4 ± 0.1 | .37 | 1 ± 1 | .53 | 0.1 ± 0.1 | .57 |
| FL | 1 ± .3 | 19 ± 4 | 0.2 ± .07 | 2 ± 1 | 0.1 ± 0.03 |
P values indicate the significance of the difference in expression of a particular receptor between tissue types: cord blood (CB)- vs fetal liver (FL)-derived CD34+ HPCs.